Gland Pharma Ltd.
BSE: 543245 | Sector: Health care |
NSE: GLAND | ISIN Code: INE068V01023 |
BSE 00:00 | 06 Jul | 2574.55 |
44.55 (1.76%) |
OPEN
2548.00 |
HIGH
2596.60 |
LOW
2500.45 |
NSE 00:00 | 06 Jul | 2584.75 |
58.65 (2.32%) |
OPEN
2539.90 |
HIGH
2598.00 |
LOW
2501.35 |
OPEN | 2548.00 |
PREVIOUS CLOSE | 2530.00 |
VOLUME | 18974 |
52-Week high | 4350.00 |
52-Week low | 2498.00 |
P/E | 34.97 |
Mkt Cap.(Rs cr) | 42,403 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Gland Pharma Ltd.
Gland Pharma Ltd was incorporated as Gland Pharma Private Limited' a private limited company under the Companies Act 1956 on March 20 1978 and was granted the certificate of incorporation by Registrar of Companies Andhra Pradesh at Hyderabad. Subsequently the name of the Company was changed to Gland Pharma Limited' pursuant to a special resolution passed by the shareholders of the Company on Decem...> More
Gland Pharma Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
42,403 | |
EPS - TTM | (![]() |
[*S] | 73.62 |
P/E Ratio | (X) | [*S] | 34.97 |
Face Value | (![]() |
1 | |
Latest Dividend | (%) | - | |
Latest Dividend Date | - | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 434.74 |
P/B Ratio | (![]() |
[*S] | 5.92 |
News
Announcement
-
Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Result
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Gland Pharma Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 1103.01 | 887.75 | 24.25 |
Other Income | 65.23 | 47.21 | 38.17 |
Total Income | 1168.25 | 934.96 | 24.95 |
Total Expenses | 754.66 | 560.08 | 34.74 |
Operating Profit | 413.59 | 374.89 | 10.32 |
Net Profit | 285.9 | 260.41 | 9.79 |
Equity Capital | 16.43 | 16.36 | - |
Gland Pharma Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Cipla | 945.85 | 0.87 | 76320.64 |
Dr Reddy's Labs | 4393.80 | 0.10 | 73130.41 |
Torrent Pharma. | 2898.85 | 0.24 | 49054.34 |
Gland Pharma | 2574.55 | 1.76 | 42402.84 |
Piramal Enterp. | 1711.20 | 0.91 | 40837.79 |
Abbott India | 19189.85 | 3.00 | 40778.43 |
Biocon | 320.80 | 2.26 | 38515.25 |
Gland Pharma Ltd - SHAREHOLDING PATTERN
|
|
Gland Pharma Ltd - Research Reports
Date | Broker | Action | Price | Report |
01/12/2021 | Emkay Global | Buy | 3608 | ![]() |
22/07/2021 | Motilal Oswal | Buy | 3802 | ![]() |
18/05/2021 | Motilal Oswal | Buy | 2800 | ![]() |
Gland Pharma Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -2.93% | -2.66% | 1.37% | 1.21% |
1 Month | -9.56% | -9.10% | -3.46% | -3.50% |
3 Month | -22.90% | -22.51% | -9.83% | -10.21% |
6 Month | -34.92% | -35.07% | -9.82% | -9.90% |
1 Year | -24.48% | -24.02% | 1.68% | 1.08% |
3 Year | NA | NA | 36.03% | 35.38% |
Gland Pharma Ltd - STOCK STRENGTH
Today's Low/High | 2500.45 | 2596.60 | |
Week Low/High | 2500.45 | 2718.00 | |
Month Low/High | 2498.00 | 2865.00 | |
YEAR Low/High | 2498.00 | 4350.00 | |
All TIME Low/High | 1701.00 | 4350.00 |
Quick Links for Gland Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices